Justin J. Lampropoulos's most recent trade in Merit Medical Systems, Inc. was a trade of 9,681 Non-qualified stock options (right to buy) done . Disclosure was reported to the exchange on March 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 9,681 | 9,681 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Sale of securities on an exchange or to another person at price $ 59.58 per share. | 12 Mar 2021 | 25,000 | 2,343 (0%) | 0% | 59.6 | 1,489,500 | Common Stock, No Par Value |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 20,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.27 per share. | 12 Mar 2021 | 20,000 | 27,343 (0%) | 0% | 17.3 | 345,400 | Common Stock, No Par Value |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.06 per share. | 12 Mar 2021 | 5,000 | 7,343 (0%) | 0% | 12.1 | 60,300 | Common Stock, No Par Value |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 5,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 3,315 | 3,315 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems Inc | Justin J. Lampropoulos | PRESIDENT, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.72 per share. | 26 Feb 2021 | 972 | 2,343 (0%) | 0% | 55.7 | 54,160 | Common Stock, No Par Value |